CIBC Bancorp USA
BMY icon

CIBC Bancorp USA’s Bristol-Myers Squibb BMY Stock Holding History

CIBC Bancorp USA’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29.4M Sell
471,632
-130,021
-22% -$8.22M 0.04% 341
2026
Q2 		$34.7M Sell
601,653
-104,455
-15% -$6M 0.04% 311
2026
Q1 		$42.8M Buy
+706,108
New +$41.2M 0.06% 247
2025
Q3 		$12.7M Buy
+280,805
New +$13.1M 0.07% 215

Other funds holding BMY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Independent Franchise Partners
Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

CIBC Bancorp USA's BMY Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Bristol-Myers Squibb (BMY) stake by 22% in Q3 2026, selling an estimated $8.22M and leaving 471,632 shares worth $29.4M. The position accounts for 0.04% of the portfolio, ranked #341.

CIBC Bancorp USA first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $42.8M in Q1 2026. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • CIBC Bancorp USA held 471,632 shares of Bristol-Myers Squibb worth $29.4M as of Q3 2026.
  • CIBC Bancorp USA sold 130,021 Bristol-Myers Squibb shares in Q3 2026, an estimated $8.22M.
  • Bristol-Myers Squibb made up 0.04% of CIBC Bancorp USA's portfolio in Q3 2026, its #341 holding.
  • CIBC Bancorp USA first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Bristol-Myers Squibb position peaked at $42.8M in Q1 2026.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.